-
Mashup Score: 2“I’m not asking to be let off”—suspended climate activist GP Sarah Benn continues to stand her ground - 9 hour(s) ago
Sarah Benn—the first doctor to face disciplinary action after being convicted and jailed for actions relating to climate activism—tells Adele Waters why suspension from the medical register will not stop her protesting “I don’t feel guilty. I don’t feel I’ve dishonoured the profession, and I think I could explain myself very well to anybody who thought that I had,” says Sarah Benn, climate activist and former general practitioner. Fresh from the decision by the UK’s Medical Practitioners Tribunal Service (MPTS) on 23 April to suspend her from the professional register for five months,1 she finds the situation clear: the activism that led to her suspension was necessary to raise the alarm over the climate crisis and was also in keeping with a doctor’s mission to promote health and save lives. “The world is facing an unprecedented crisis due to the danger of climate and ecological collapse, and I believe that my actions are a justified and proportionate effort to raise an alarm about the
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2“I’m not asking to be let off”—suspended climate activist GP Sarah Benn continues to stand her ground - 17 hour(s) ago
Sarah Benn—the first doctor to face disciplinary action after being convicted and jailed for actions relating to climate activism—tells Adele Waters why suspension from the medical register will not stop her protesting “I don’t feel guilty. I don’t feel I’ve dishonoured the profession, and I think I could explain myself very well to anybody who thought that I had,” says Sarah Benn, climate activist and former general practitioner. Fresh from the decision by the UK’s Medical Practitioners Tribunal Service (MPTS) on 23 April to suspend her from the professional register for five months,1 she finds the situation clear: the activism that led to her suspension was necessary to raise the alarm over the climate crisis and was also in keeping with a doctor’s mission to promote health and save lives. “The world is facing an unprecedented crisis due to the danger of climate and ecological collapse, and I believe that my actions are a justified and proportionate effort to raise an alarm about the
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry - 17 hour(s) ago
The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports At his public confirmation hearing in late 2021, Robert Califf, President Biden’s nominee to lead the US Food and Drug Administration (FDA), faced pointed questions about his financial relationships with industry. Bernie Sanders, the senator from Vermont, asked, “At a time when the American people are outraged by the high cost of prescription drugs, deeply disturbed about what happened with Purdue and Oxycontin, what kind of comfort can you give to the American people when you have been so closely tied to the pharmaceutical industry yourself?” He added, “How can the American people feel comfortable you’re going to stand up to this powerful special interest?” Califf responded: “Senator Sanders, I have a history of doing that. But I’d also point out that this administration has the most stringent ethic
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis - 7 day(s) ago
Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished and international literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ProQuest Dissertations and Theses Global, and PsycEXTRA), and handsearching of reference lists, conference proceedings, and abstracts. Data synthesis and study quality Information on potential treatment effect moderators was extracted, including depression type (primary or secondary), previous use of psychedelics, psilocybin dosage, type of outcome measure (clinician rated or self-reported), and personal characteristics (eg, age, sex). Data were synthesised using a random effects meta-
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Biomarkers of metal exposure in adolescent e-cigarette users: correlations with vaping frequency and flavouring - 7 day(s) ago
Background Youth vaping poses a significant public health concern as metals have been detected in e-cigarette aerosols and liquids. This study investigated factors associated with biomarkers of metal exposure. Methods Data were drawn from Wave 5 of the Population Assessment of Tobacco and Health (PATH) Study Youth Panel, a nationally representative sample of US adolescents aged 13–17 years. Urinary biomarkers of exposure to cadmium, lead, and uranium were assessed by vaping frequency (occasional (1–5 days), intermittent (6–19 days), and frequent (20+ days)) in the past 30 days and flavour type (menthol/mint, fruit, and sweet). Results Among 200 exclusive e-cigarette users (median age 15.9 years, 62.9% female), 65 reported occasional use, 45 reported intermittent use, and 81 reported frequent use. The average number of recent puffs per day increased exponentially by vaping frequency (occasional: 0.9 puffs, intermittent: 7.9 puffs, frequent: 27.0 puffs; p=0.001). Both intermittent (0.21
Source: tobaccocontrol.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 23Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis - 8 day(s) ago
Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished and international literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ProQuest Dissertations and Theses Global, and PsycEXTRA), and handsearching of reference lists, conference proceedings, and abstracts. Data synthesis and study quality Information on potential treatment effect moderators was extracted, including depression type (primary or secondary), previous use of psychedelics, psilocybin dosage, type of outcome measure (clinician rated or self-reported), and personal characteristics (eg, age, sex). Data were synthesised using a random effects meta-
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis - 8 day(s) ago
Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished and international literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ProQuest Dissertations and Theses Global, and PsycEXTRA), and handsearching of reference lists, conference proceedings, and abstracts. Data synthesis and study quality Information on potential treatment effect moderators was extracted, including depression type (primary or secondary), previous use of psychedelics, psilocybin dosage, type of outcome measure (clinician rated or self-reported), and personal characteristics (eg, age, sex). Data were synthesised using a random effects meta-
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Clinical and neuroradiographic features of fentanyl inhalation-induced leukoencephalopathy - 9 day(s) ago
A man in his late 40s with no known past medical history was unresponsive for an unknown period of time. Crushed pills and white residue were found on a nearby table. On presentation he was obtunded and unresponsive to verbal commands but withdrawing to painful stimuli. The initial urine drug screen was negative, but a urine fentanyl screen was subsequently positive with a level of 137.3 ng/mL. MRI of the brain showed reduced diffusivity and fluid attenuated inversion recovery (FLAIR) hyperintensity symmetrically in the bilateral supratentorial white matter, cerebellum and globus pallidus. Alternative diagnoses such as infection were considered, but ultimately the history and workup led to a diagnosis of fentanyl-induced leukoencephalopathy. Three days after admission the patient became able to track, respond to voice and follow basic one-step commands. The patient does not recall the mechanism of inhalation. While there are case reports of heroin-induced leukoencephalopathy following
Source: casereports.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Webinars - 9 day(s) ago
Our year round series of webinars look to the future of health, providing valuable insights, evidence and practical knowledge in critical digital health areas. Featuring leading experts, frontline clinicians, researchers, and industry leaders, our three streams cater to diverse interests and needs. “How to” webinars to help you top up your digital skills or dip your toe in the world of innovations in health. “Spotlight “webinars taking a deep dive with the experts into some of the more complex issues
Source: futurehealth.bmj.comCategories: General Medicine News, General HCPsTweet-
We are fuelling your innovation journey with BMJ Future Health Webinars series. Join us on 7 May @ 12:00 BST for the first of our FREE webinars. Pitching the problem: How to explain what needs fixing to the people who can help you fix it. FREE booking. https://t.co/Qbbrdcr3dO https://t.co/riW5EOeMTe
-
-
Mashup Score: 5Meet our BMJ Journal Editors - 10 day(s) ago
Listen to our BMJ journal editors talk about what makes their journal special and why it is appealing to both readers and authors.
Source: fast.wistia.netCategories: General Medicine News, General HCPsTweet
Suspended climate activist GP tells @bmj_latest she will not stop protesting https://t.co/NZRKKlelGG https://t.co/WN6wE4HdSE